Uterine wall thickening, particularly endometrial hyperplasia, can manifest as abnormal and heavy uterine bleeding, potentially leading to anemia. Of significant concern is atypical endometrial hyperplasia, which, if left untreated, carries a substantial risk of malignant transformation. Specifically, endometrial cancer develops in approximately 8% of women with untreated simple atypical endometrial hyperplasia and in roughly 30% of those with untreated complex atypical endometrial hyperplasia.